Fact sheet
| CEO | Andrin Oswald |
| Headquarters | Cambridge, Massachusetts |
| Major R&D sites | Cambridge, Massachusetts |
| Emeryville, California | |
| Siena, Italy |
| Major production sites | Ankelshwar, India |
| Holly Springs, North Carolina | |
| (under construction) | |
| Siena/Rosia, Italy | |
| Marburg, Germany | |
| Liverpool, England |
| Web site address |
| 2008 net sales | USD 1.8 billion |
| 2008 full-time associates |
4 774 |
| Leading products Influenza |
Agrippal Fluad Fluvirin Optaflu |
| Meningitis | Menjugate |
| Pediatric/traveler | Begrivac Dif-Tet-All Encepur HAVpur IPV-Virelon Polioral Quinvaxem Rabipur/Rabavert Td-pur and Td-Virelon Tetanol/Tetanol pur Vaxem Hib |
| Blood testing | Procleix range of products for testing blood samples |
Disease & products
Learn about meningitis, influenza, rabies, TBE and japanese encephalities.
About Novartis Vaccines
Novartis Vaccines is the world's fifth-largest vaccines business.
Business Development & Licensing
Finding new partnership to develop new vaccines is one of the BD&L team mission.